THEY SAID IT! E&C Lawmakers Pledge Bipartisan Action To Boost Transparency, Hold Big Pharma Accountable & Lower Drug Prices

05-22-2019 Press Release

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The U.S. House Energy & Commerce Subcommittee on Health held a hearing on drug pricing transparency Tuesday.  During the hearing, lawmakers from both sides of the aisle blasted Big Pharma for the industry’s anti-competitive and price-gouging tactics.  Members of the committee also rallied behind […]

Lawmakers Keeping Up Bipartisan Momentum On Drug Pricing

05-21-2019 Press Release

House Energy & Commerce Subcommittee Takes Up Transparency Bills Tuesday Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement ahead of a U.S. House Energy & Commerce Subcommittee on Health hearing on improving drug pricing transparency on Capitol Hill: “We applaud House lawmakers for keeping up the bipartisan momentum to […]

“Dose of Reality” Breaking Down the Big Pharma Dollar

05-18-2019 Press Release

Part IV:  Big Pharma’s Tax Conundrum The average American spends $1,200 per year out-of-pocket on prescription drugs.  Altogether, the 10 largest U.S.-based Big Pharma drug manufacturers pulled in a colossal $245 billion in revenue in just one year. As prescription drug prices continue to climb, causing one in four Americans to not be able to […]

“Dose of Reality” Breaking Down the Big Pharma Dollar

05-17-2019 Press Release

Part III:  As Prices Rise, So Too Does Ad Spending The average American spends $1,200 per year out-of-pocket on prescription drugs.  Altogether, the 10 largest U.S.-based Big Pharma drug manufacturers pulled in a colossal $245 billion in revenue in just one year. As prescription drug prices continue to climb, causing one in four Americans to […]

CSRxP: House Passage of Bipartisan CREATES Act a Pivotal Moment for Patients

05-16-2019 Press Release

Applauds Lawmakers for Advancing Market-Based Solutions to Lower Drug Prices After Years of Opposition from Big Pharma For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement praising lawmakers in the U.S. House of Representatives for passing a pair of bipartisan drug pricing […]

“Dose of Reality” Breaking Down the Big Pharma Dollar

05-16-2019 Press Release

Part II: An Industry Booming Off of Price-Gouging The average American spends $1,200 per year out-of-pocket on prescription drugs.  Altogether, the 10 largest U.S.-based Big Pharma drug manufacturers pulled in a colossal $245 billion in revenue in just one year. As prescription drug prices continue to climb, causing one in four Americans to not be […]

CSRxP Encourages U.S. House of Representatives to Pass Bipartisan CREATES Act

05-16-2019 Press Release

Commends Lawmakers of Both Parties for Working Together to Advance Key Drug Pricing Measures Through Committee Process For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement encouraging the U.S. House of Representatives to pass the bipartisan CREATES Act and Protecting Consumer Access […]

“Dose of Reality” Breaking Down the Big Pharma Dollar

05-15-2019 Press Release

Part I: The Math Undercuts the R&D Defense The average American spends $1,200 per year out-of-pocket on prescription drugs.  Altogether, the 10 largest U.S.-based Big Pharma drug manufacturers pulled in a colossal $245 billion in revenue in just one year. As prescription drug prices continue to climb, causing one in four Americans to not be […]

CSRxP Applauds Bipartisan Bill To Strengthen Drug Pricing Transparency

05-14-2019 Press Release

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement applauding the introduction of a bill by Senators Chuck Grassley (R-IA) and Richard Durbin (D-IL) that will codify the U.S. Department of Health and Human Services’ (HHS) direct-to-consumer advertising (DTC) rule: “We applaud […]

CSRxP Study Confirms: Big Pharma Invests Boldly in Profits and Advertising — Not R&D

05-14-2019 Press Release

Analysis Finds Industry Spending on Advertising, Overhead and Profits More Than Double Funding for R&D For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the findings of a study Wednesday that found the largest pharmaceutical manufacturers in the U.S. spend just 22 cents out of […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.